aminolevulinic acid hydrochloride 0.1 MG/MG Topical Gel [Ameluz]

RxNorm concept 1806650, branded drug (sbd). Prescribable name: Ameluz 10 % Topical Gel.

RxCUI: 1806650
Term type: Branded drug (SBD)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/1806650 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

aminolevulinic acid 683

Other names

Ameluz 0.1 MG/MG Topical Gel; Ameluz 10 % Topical Gel

Related concepts

aminolevulinic acid hydrochloride 0.1 MG/MG (SCDC, consists of)
aminolevulinic acid hydrochloride 0.1 MG/MG [Ameluz] (SBDC, consists of)
Topical Gel (DF, has dose form)
Ameluz (BN, has ingredient)
aminolevulinic acid hydrochloride 0.1 MG/MG Topical Gel (SCD, tradename of)

Linked data

NDCs

NDC-11s RxNorm links to this concept; linked ones open their FDA product.

Use it

Look up 1806650 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/1806650 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 1806650. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.